论文部分内容阅读
目的 介绍经髂外动脉 (IEA)入路药盒导管系统 (PCS)植入术的方法、并发症及处理 ,并探讨其可行性及优越性。方法 110例肝脏中晚期恶性肿瘤患者 ,男 86例 ,女 2 4例 ,平均年龄 50 .8岁 ,其中原发性肝癌 68例 ,肝转移瘤 42例。均行经IEA入路植入PCS。随访 2～ 53个月。结果 手术成功率 98.2 % (10 8/ 110 )。并发症 :穿刺局部血肿 5例 (4.5% ) ,药盒囊腔切口感染 1例(0 .9% ) ,药盒囊腔内慢性出血 2例 (1.8% ) ,术后治疗过程中靶血管闭塞或严重狭窄 6例 (5.5% ) ,右侧睾丸轻度胀痛 1例 (0 .9% ) ,留置导管移位 3例 (2 .7% )。并发症发生率 15.5%。结论 经IEA入路PCS植入术是安全可行的 ,且成功率高、并发症发生率低 ,可做为一种常规方法推广应用
Objective To introduce the methods, complications and treatment of the catheterization catheterization (PCS) via the external iliac artery (IEA), and to explore its feasibility and superiority. Methods Totally 110 patients with advanced liver cancer were enrolled in this study. There were 86 males and 24 females, with an average age of 50.8 years, of which 68 were primary liver cancer and 42 were liver metastases. All patients underwent implantation of PCS via IEA. Followed up for 2 ~ 53 months. Results The success rate of operation was 98.2% (10 8/110). The complications were as follows: puncture local hematoma in 5 cases (4.5%), 1 case (0. 9%) in the cyst incision infection, 2 cases (1.8%) in the cystic cavity and target vessel occlusion Or severe stenosis in 6 cases (5.5%), right testicular mild pain in 1 case (0.9%), catheter indwelling in 3 cases (2.7%). The complication rate was 15.5%. Conclusions The PCS implantation by IEA is safe and feasible, with high success rate and low complication rate, which can be used as a routine method